1. Home
  2. Browse
  3. Drug Information
  4. Formulary/Drug Comparison

Formulary/Drug Comparison

256 - 270 of 358 Results
Sort Results:
Article: The new drug, Latuda (lah-TOO-dah, lurasidone), will compete in a crowded market of "atypical" antipsychotics (Zyprexa, Abilify, etc) September 2012
Commentary: Combining a GLP-1 Agonist and a DPP-4 Inhibitor for Type 2 Diabetes August 2012
Algorithm: Opioid Conversion Algorithm August 2012
Chart: Comparison of Injectable Anticoagulants August 2012
Article: patients getting combinations of certain diabetes meds...Victoza with Onglyza, Byetta with Januvia, etc August 2012
Article: avoiding overdoses when patients switch opioid pain medications (oxycodone, morphine, hydromorphone, etc) August 2012
Article: Techs will continue to be challenged by Rxs for "cephalosporin" antibiotics July 2012
Article: Toviaz (TOE-vee-az, fesoterodine) will add to the confusion in the crowded market of overactive bladder drugs July 2012
Article: whether Botox and various supplements work to prevent migraine headaches July 2012
Guideline: Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults : Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society (2012) July 2012
Article: patients on statins (atorvastatin, simvastatin, etc) will get fewer liver function lab tests May 2012
Commentary: Thiazides for Hypertension February 2012
Commentary: Combination Therapy for Hypertension February 2012
Commentary: Carisoprodol: Schedule IV Controlled Substance Nationwide January 2012
Archive: A Note from Your Pharmacist: Carisoprodol (Soma) is a Controlled Substance January 2012